{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:51:56Z","timestamp":1789750316668,"version":"4.0.1"},"reference-count":173,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Preeclampsia is a serious, pregnancy-specific, multi-organ disease process of compound aetiology. It affects 3\u20136% of expecting mothers worldwide and it persists as a leading cause of maternal and foetal morbidity and mortality. In fact, hallmark features of preeclampsia (PE) result from vessel involvement and demonstrate maternal endothelium as a target tissue. Growing evidence suggests that chronic placental hypoperfusion triggers the production and release of certain agents that are responsible for endothelial activation and injury. In this review, we will present the latest findings on the role of nitric oxide, asymmetric dimethylarginine (ADMA), and homocysteine in the etiopathogenesis of preeclampsia and their possible clinical implications.<\/jats:p>","DOI":"10.3390\/ijms20112757","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T03:38:01Z","timestamp":1559792281000},"page":"2757","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["The Role of Nitric Oxide, ADMA, and Homocysteine in The Etiopathogenesis of Preeclampsia\u2014Review"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0822-0350","authenticated-orcid":false,"given":"Weronika","family":"Dymara-Konopka","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Perinatology, Medical University of Lublin, Poland, 20-950 Lublin, Jaczewskiego 8, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"Laskowska","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Perinatology, Medical University of Lublin, Poland, 20-950 Lublin, Jaczewskiego 8, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: A systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"ref_3","unstructured":"American College of Obstetricians and Gynecologists, and Task Force on Hypertension in Pregnancy (2013). Hypertension in Pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet. Gynecol., 122, 1122\u20131131."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.preghy.2012.11.001","article-title":"The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP)","volume":"3","author":"Tranquilli","year":"2013","journal-title":"Pregnancy Hypertens."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: An endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The two stage model of preeclampsia: Variations on the theme","volume":"30","author":"Roberts","year":"2009","journal-title":"Placenta"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.7985020","article-title":"Implantation and the placenta: Key pieces of the development puzzle","volume":"266","author":"Cross","year":"1994","journal-title":"Science"},{"key":"ref_8","first-page":"177","article-title":"The role of the spiral arteries in the pathogenesis of preeclampsia","volume":"1","author":"Brosens","year":"1972","journal-title":"Obstet. Gynecol. Annu."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/HYPERTENSIONAHA.107.107607","article-title":"Placental origins of preeclampsia: Challenging the current hypothesis","volume":"51","author":"Huppertz","year":"2008","journal-title":"Hypertension"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt-1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14767050400028816","article-title":"Plasma soluble vascular endothelial growth factor receptor -1 concentration is elevated prior to the cinical diagnosis of preeclampsia","volume":"17","author":"Chaiworapongsa","year":"2005","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2174\/1389201019666180925115559","article-title":"Angiogenic Imbalance as a Contributor of Preeclampsia","volume":"19","author":"Laskowska","year":"2018","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_14","first-page":"33","article-title":"Pathophysiology of hypertension in preeclampsia","volume":"13","author":"Harihana","year":"2016","journal-title":"Clin. Pract."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/j.1523-1755.2005.00316.x","article-title":"Preeclampsia: A renal perspective","volume":"67","author":"Karumanchi","year":"2005","journal-title":"Kidney Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.preghy.2012.01.001","article-title":"The Placenta in Preeclampsia","volume":"2","author":"Roberts","year":"2012","journal-title":"Pregnancy Hypertens"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/uog.15741","article-title":"Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancy","volume":"48","author":"Ferrazzi","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.placenta.2013.12.008","article-title":"IFPA Senior Award Lecture: Making sense of pre-eclampsia","volume":"35","author":"Redman","year":"2014","journal-title":"Placenta"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"14606","DOI":"10.3390\/ijms131114606","article-title":"Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming","volume":"13","author":"Huang","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_20","first-page":"208","article-title":"Recent insights into the roles of nitric oxide and renin-angiotensin in the pathophysiology of preeclamptic pregnancy","volume":"18","author":"Baylis","year":"1998","journal-title":"Semin. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1006\/niox.2000.0296","article-title":"Nitric oxide dysfunction in the pathophysiology of preeclampsia","volume":"4","author":"Lowe","year":"2000","journal-title":"Nitric Oxide"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3109\/01443615.2012.693985","article-title":"The role of homocysteine, asymmetric dimethylarginine and nitric oxide in preeclampsia","volume":"32","author":"Demir","year":"2012","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1152\/ajpregu.00762.2001","article-title":"Vascular mechanisms of increased arterial pressure in preeclampsia: Lessons from animal models","volume":"283","author":"Khalil","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0140-6736(93)92335-Q","article-title":"Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and preeclampsia","volume":"342","author":"Fickling","year":"1993","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"112 e111","DOI":"10.1016\/j.ajog.2007.05.052","article-title":"Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants","volume":"198","author":"Speer","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0002-9378(98)70437-5","article-title":"Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia","volume":"178","author":"Holden","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1034\/j.1600-0412.1998.770805.x","article-title":"Increased circulating concentrations of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia","volume":"77","author":"Pettersson","year":"1998","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0301-2115(00)00282-7","article-title":"Hyperhomocysteinemia and pregnancy\u2014Review of our present understanding and therapeutic implications","volume":"93","author":"Aubard","year":"2000","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1161\/hc4601.098514","article-title":"Homocysteine impairs the nitric oxide synthase pathway: Role of asymmetric dimethylarginine","volume":"104","author":"Tsao","year":"2001","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1515\/CCLM.2005.198","article-title":"Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status","volume":"43","author":"Herrmann","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/01.HYP.16.5.477","article-title":"Nitric oxide. A novel signal transduction mechanism for transcellular communication","volume":"16","author":"Ignarro","year":"1990","journal-title":"Hypertension"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrd2466","article-title":"The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics","volume":"7","author":"Lundberg","year":"2008","journal-title":"Nat. Rev. Drug. Discovery"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/1440-1681.12136","article-title":"Endothelial caveolar subcellular domain regulation of endothelial nitric oxide synthase","volume":"40","author":"Ramadoss","year":"2013","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2174\/138920111798281063","article-title":"Exercise-induced modulation of endothelial nitric oxide production","volume":"12","author":"Gielen","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.niox.2015.01.006","article-title":"Endothelium microenvironment sensing leading to nitric oxide mediated vasodilation: A review of nervous and biomechanical signals","volume":"45","author":"Quillon","year":"2015","journal-title":"Nitric Oxide"},{"key":"ref_37","first-page":"R441","article-title":"Nitric oxide and pregnancy","volume":"272","author":"Sladek","year":"1997","journal-title":"Am. J. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1271\/bbb.90222","article-title":"Changes in nitric oxide production levels and expression of nitric oxide synthase isoforms in the rat uterus during pregnancy","volume":"73","author":"Suzuki","year":"2009","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/molehr\/5.5.467","article-title":"Nitric oxide synthase distribution during implantation in the mouse","volume":"5","author":"Purcell","year":"1999","journal-title":"Mol. Hum. Reprod."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1113\/jphysiol.2006.104968","article-title":"Placental adaptive responses and fetal programming","volume":"572","author":"Myatt","year":"2006","journal-title":"J. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.RES.85.3.247","article-title":"Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase C activity","volume":"85","author":"Shizukuda","year":"1999","journal-title":"Circ. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/bj3380367","article-title":"Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells","volume":"338","author":"Frank","year":"1999","journal-title":"Biochem. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/HYPERTENSIONAHA.111.187559","article-title":"Endothelial nitric oxide synthase deficiency reduces uterine blood flow, spiral artery elongation, and placental oxygenation in pregnant mice","volume":"60","author":"Kulandavelu","year":"2012","journal-title":"Hypertension"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/152308603321223612","article-title":"Regulation of vascular endothelial growth factor synthesis by nitric oxide: Facts and controversies","volume":"5","author":"Dulak","year":"2003","journal-title":"Antioxid. Redox. Signal."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.ATV.0000128897.54893.26","article-title":"Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway","volume":"24","author":"Vallance","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.phrs.2009.08.002","article-title":"Cellular ADMA: Regulation and action","volume":"60","author":"Teerlink","year":"2009","journal-title":"Pharmacol. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/157340310791162659","article-title":"The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease","volume":"6","author":"Sibal","year":"2010","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0100-879X2009007500021","article-title":"Genetics of homocysteine metabolism and associated disorders","volume":"43","author":"Brustolin","year":"2010","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0002-9378(99)70269-3","article-title":"Changes in homocysteine levels during normal pregnancy","volume":"180","author":"Walker","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/jn\/129.5.919","article-title":"Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement","volume":"129","author":"Bailey","year":"1999","journal-title":"J. Nutr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ng0694-195","article-title":"Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping, and mutation identification","volume":"7","author":"Goyette","year":"1994","journal-title":"Nat. Genet."},{"key":"ref_52","first-page":"745","article-title":"Homocysteine as a risk factor for cardiovascular disease: Should we (still) worry about it?","volume":"136","author":"Faeh","year":"2006","journal-title":"Swiss Med. Wkly."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.5604\/17322693.1102340","article-title":"Hyperhomocysteinemia in patients with cardiovascular disease","volume":"68","author":"Baszczuk","year":"2014","journal-title":"Postepy Hig. Med. Dosw."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(98)11058-9","article-title":"Homocysteine and vascular disease","volume":"354","author":"Hankey","year":"1999","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/clinchem\/44.1.102","article-title":"Variability and determinants of total homocysteine concentrations in plasma in an elderly population","volume":"44","author":"Clarke","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_56","unstructured":"Thrombosis Interest Group of Canada (2015, June 17). Thrombophilia: Homocysteinemia and Methylene Tetrahydrofolate Reductase. Available online: http:\/\/thrombosiscanada.ca\/?page_id=18#."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s11064-014-1338-7","article-title":"Toxic effects of mildly elevated homocysteine concentrations in neuronal-like cells","volume":"39","author":"Curro","year":"2014","journal-title":"Neurochem. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0021-9150(00)00671-7","article-title":"The 1298A\u2192C polymorphism in methylenetetrahydrofolate reductase (MTHFR): In vitro expression and association with homocysteine","volume":"156","author":"Weisberg","year":"2001","journal-title":"Atherosclerosis"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00392-004-0075-3","article-title":"Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases","volume":"93","author":"Stanger","year":"2004","journal-title":"Z. Kardiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.acvd.2009.07.002","article-title":"The controversial role of B-vitamins in cardiovascular risk: An update","volume":"102","author":"Ntaios","year":"2009","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_61","first-page":"111","article-title":"Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am. J. Pathol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.med.49.1.31","article-title":"Homocysteine and cardiovascular disease","volume":"49","author":"Refsum","year":"1998","journal-title":"Annu. Rev. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0369-8114(03)00104-4","article-title":"Hyperhomocysteinemia: An independent risk factor or a simple marker of vascular disease?. 1. Basic data","volume":"51","author":"Guilland","year":"2003","journal-title":"Pathol. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jvs.2013.01.046","article-title":"Plasma total homocysteine is associated with abdominal aortic aneurysm and aortic diameter in older men","volume":"58","author":"Wong","year":"2013","journal-title":"J. Vasc. Surg."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/bph.13988","article-title":"Hyperhomocysteinaemia and vascular injury: Advances in mechanisms and drug targets","volume":"175","author":"Fu","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(03)00438-1","article-title":"Homocysteine and Alzheimer\u2019s disease","volume":"2","author":"Morris","year":"2003","journal-title":"Lancet Neurol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma Homocysteine as a risk factor for dementia and Alzheimer\u2019s disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/01.STR.0000032550.90046.38","article-title":"Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland","volume":"33","author":"McIlroy","year":"2002","journal-title":"Stroke"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1468-1331.2011.03534.x","article-title":"Increased plasma levels of total homocysteine but not asymmetric dimethylarginine in Hispanic subjects with ischemic stroke FREC-VI sub-study","volume":"19","author":"Bedoya","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1515\/CCLM.2005.194","article-title":"Homocysteine\u2013a newly recognised risk factor for osteoporosis","volume":"43","author":"Herrmann","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/j.jrn.2011.10.008","article-title":"Hyperhomocysteinemia in chronic renal failure: Alternative therapeutic strategies","volume":"22","author":"Perna","year":"2012","journal-title":"J. Ren. Nutr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ajcn\/72.2.315","article-title":"Homocysteine and cardiovascular disease: Cause or effect?","volume":"72","author":"Wilcken","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.RES.87.5.406","article-title":"Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy","volume":"87","author":"Nelson","year":"2000","journal-title":"Circ. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"RA221","DOI":"10.12659\/MSM.881972","article-title":"Reciprocal regulation of cellular nitric oxide formation by nitric oxide synthase and nitrite reductases","volume":"17","author":"Stefano","year":"2011","journal-title":"Med. Sci. Monit."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/CIRCULATIONAHA.114.009029","article-title":"Cardiovascular physiology of pregnancy","volume":"130","author":"Sanghavi","year":"2014","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/1570161114666160222115158","article-title":"Nitric oxide is a central common metabolite in vascular dysfunction associated with diseases of human pregnancy","volume":"14","author":"Leiva","year":"2016","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_78","first-page":"F48","article-title":"Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet","volume":"277","author":"Conrad","year":"1999","journal-title":"Am. J. Physiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/0002-9378(95)90500-6","article-title":"Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy","volume":"172","author":"Buhimschi","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00041552-199801000-00010","article-title":"Measurement of nitrite and nitrate levels in plasma and urine: What does this measure tell us about the activity of the endogenous nitric oxide system?","volume":"7","author":"Baylis","year":"1998","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_81","first-page":"257","article-title":"Nitric oxide production increases during normal pregnancy and decreases in preeclampsia","volume":"32","author":"Choi","year":"2002","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_82","first-page":"523","article-title":"Maternal or umbilical venous levels of nitrite\/nitrate during pregnancy and at delivery","volume":"12","author":"Jo","year":"1998","journal-title":"In Vivo"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0020-7292(99)00213-1","article-title":"Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia","volume":"68","author":"Shaamash","year":"2000","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000010147","article-title":"Maternal circulation nitrite levels are decreased in both normal normotensive pregnancies and pregnancies with preeclampsia","volume":"48","author":"Hata","year":"1999","journal-title":"Gynecol. Obstet. Invest."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/10641959509015678","article-title":"Nitric oxide excretion in normal and hypertensive pregnancies","volume":"14","author":"Brown","year":"1995","journal-title":"Hyperten. Pregnancy"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1471-0528.1997.tb11528.x","article-title":"Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with preeclampsia","volume":"104","author":"Smarason","year":"1997","journal-title":"Br. J. Obstet. Gynecol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bcp.2015.04.012","article-title":"Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia","volume":"95","author":"Shah","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1442-200X.2012.03605.x","article-title":"Birth by cesarean section is associated with elevated neonatal plasma levels of dimethylarginines","volume":"54","author":"Vida","year":"2012","journal-title":"Pediatr. Int."},{"key":"ref_89","first-page":"377","article-title":"Decreased serum homocysteine in pregnancy","volume":"30","author":"Andersson","year":"1992","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"ref_90","first-page":"S24","article-title":"South Australian experience with hyperhomocysteinaemia as a risk factor in obstetrics. Time for a trial?","volume":"52","author":"Hague","year":"1997","journal-title":"Neth. J. Med."},{"key":"ref_91","first-page":"228","article-title":"The relationship between maternal and neonatal umbilical cord plasma homocysteine suggests a potential role for maternal homocysteine in fetal metabolism","volume":"178","author":"Malinow","year":"1998","journal-title":"Obstet. Gynecol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1471-0528.1997.tb10642.x","article-title":"Maternal and fetal levels of methionine and homocysteine in early human pregnancy","volume":"104","author":"Wathen","year":"1997","journal-title":"Br. J. Obstet. Gynecol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0301-2115(02)00367-6","article-title":"Plasma total homocysteine in uncomplicated pregnancy and in preeclampsia","volume":"108","author":"Vilaseca","year":"2003","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1471-0528.2012.03321.x","article-title":"Homocysteine and folate concentrations in early pregnancy and the risk of adverse pregnancy outcomes: The Generation R Study","volume":"119","author":"Bergen","year":"2012","journal-title":"BJOG"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0140-6736(95)90165-5","article-title":"Homocysteine metabolism in pregnancies complicated by neuraltube defects","volume":"345","author":"Mills","year":"1995","journal-title":"Lancet"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00404-015-3894-8","article-title":"Methylenetetrahydrofolate reductase gene polymorphisms and recurrent pregnancy loss in China: A systematic review and meta-analysis","volume":"293","author":"Chen","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_97","first-page":"188","article-title":"Homocysteinemia during pregnancy and placental disease","volume":"27","author":"Pollio","year":"2000","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.AOG.0000129955.47943.2a","article-title":"Hyperhomocysteinemia, pregnancy complications, and the timing of investigation","volume":"104","author":"Peer","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0002-9378(94)70064-8","article-title":"The role of nitric oxide in the pathogenesis of preeclampsia","volume":"171","author":"Seligman","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000010192","article-title":"Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery","volume":"48","author":"Ibrahimoglu","year":"1999","journal-title":"Gynecol. Obstet. Invest."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0002-9378(96)80044-5","article-title":"Evaluation of nitric oxide as a mediator of severe preeclampsia","volume":"175","author":"Silver","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00404-006-0149-8","article-title":"Plasma- and urine concentrations of nitrite\/nitrate and cyclic Guanosinemono phosphate in intrauterine growth restricted and preeclamptic pregnancies","volume":"274","author":"Schiessl","year":"2006","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1479-828X.1999.tb03139.x","article-title":"Estimation of oxidative products of nitric oxide (nitrates, nitrites) in preeclampsia","volume":"39","author":"Pathak","year":"1999","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.HYP.33.1.435","article-title":"Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats","volume":"33","author":"Alexander","year":"1999","journal-title":"Hypertension"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/HYPERTENSIONAHA.109.132191","article-title":"Plasma-Mediated Vascular Dysfunction in the Reduced Uterine Perfusion Pressure Model of Preeclampsia: A Microvascular Characterization","volume":"54","author":"Walsh","year":"2009","journal-title":"Hypertension"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0891-5849(03)00406-4","article-title":"Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals","volume":"35","author":"Kleinbongard","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0008-6363(98)00259-4","article-title":"Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: Evidence for biochemical assessment of the endothelial L-arginine-NO pathway","volume":"41","author":"Kelm","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/hr.2013.34","article-title":"L-arginine-nitric oxide pathway and oxidative stress in plasma and platelets of patients with pre-eclampsia","volume":"36","author":"Pimentel","year":"2013","journal-title":"Hypertens. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cca.2013.04.027","article-title":"Relationship between adiponectin and nitrite in healthy and preeclampsia pregnancies","volume":"423","author":"Eleuterio","year":"2013","journal-title":"Clin. Chim. Acta."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/HYPERTENSIONAHA.108.115006","article-title":"Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia","volume":"52","author":"Sandrim","year":"2008","journal-title":"Hypertension"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.placenta.2011.08.008","article-title":"Nitric oxide generation affects pro- and anti-angiogenic growth factor expression in primary human trophoblast","volume":"32","author":"Groesch","year":"2011","journal-title":"Placenta"},{"key":"ref_112","first-page":"15275","article-title":"Homocysteine, endothelin-1 and nitric oxide in patients with hypertensive disorders complicating pregnancy","volume":"8","author":"Zeng","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1152\/ajprenal.2001.280.4.F592","article-title":"Chronic NOS inhibition reverses systemic vasodi- lation and glomerular hyperfiltration in pregnancy","volume":"280","author":"Cadnapaphornchai","year":"2001","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/14767058.2014.900036","article-title":"The relation of maternalserum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and\/or intrauterine fetal growth restriction","volume":"28","author":"Laskowska","year":"2015","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preghy.2012.04.246","article-title":"PP135. Maternal serum levels of endothelial nitric oxide synthase and ADMA, an endogenous ENOS inhibitor in pregnancies complicated by severe preeclampsia","volume":"2","author":"Laskowska","year":"2012","journal-title":"Pregnancy Hypertens."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/humrep\/12.1.167","article-title":"Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies","volume":"12","author":"Myatt","year":"1997","journal-title":"Hum. Reprod."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.placenta.2015.02.001","article-title":"Placental expression of eNOS, iNOS and the major protein components of caveolae in women with preeclampsia","volume":"36","author":"Hentschke","year":"2015","journal-title":"Placenta"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/10641959909023071","article-title":"Nitric oxide synthase activity and Doppler parameters in the fetoplacental and uteroplacental circulation in preeclampsia","volume":"18","author":"Beinder","year":"1999","journal-title":"Hypertens. Pregnancy"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1440-1681.2003.03844.x","article-title":"Placental endothelial nitric oxide synthase localization and expression in normal human pregnancy and preeclampsia","volume":"30","author":"Orange","year":"2003","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"R499","DOI":"10.1152\/ajpregu.00355.2017","article-title":"Animal models of preeclampsia: Translational failings and why","volume":"314","author":"Marshall","year":"2018","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.niox.2016.05.004","article-title":"Sodium nitrite attenuates hypertension- in-pregnancy and blunts increases in soluble fms-like tyrosine kinase-1 and in vascular endothelial growth factor","volume":"57","author":"Nascimento","year":"2016","journal-title":"Nitric Oxide"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/jhh.2011.109","article-title":"Asymmetric dimethylarginine, arginine and homoarginine at 11-13 weeks\u2019 gestation and preeclampsia: A case-control study","volume":"27","author":"Khalil","year":"2013","journal-title":"J. Hum. Hypertens."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/1471-0528.13516","article-title":"Serial determinations of asymmetric dimethylarginine and homocysteine during pregnancy to predict pre-eclampsia: A longitudinal study","volume":"122","year":"2015","journal-title":"BJOG"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/10641963.2015.1089880","article-title":"Assessment of ADMA, estradiol, and progesterone in severe preeclampsia","volume":"38","author":"Zheng","year":"2016","journal-title":"Clin. Exp. Hypertens."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"430","DOI":"10.12659\/MSM.883932","article-title":"A comparison of maternal serum levels of endothelial nitric oxide synthase, asymmetric dimethylarginine, and homocysteine in normal and preeclamptic pregnancies","volume":"19","author":"Laskowska","year":"2013","journal-title":"Med. Sci. Monit."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.niox.2013.07.006","article-title":"Assessment of L-arginine asymmetric 1 dimethyl (ADMA) in early-onset and late-onset (severe) preeclampsia","volume":"33","author":"Alpoim","year":"2013","journal-title":"Nitric Oxide"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Bian, Z., Shixia, C., and Duan, T. (2015). First-trimester maternal serum levels of sFLT1, PGF and ADMA predict preeclampsia. PLoS One, 10.","DOI":"10.1371\/journal.pone.0124684"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3109\/14767058.2011.632037","article-title":"Levels of asymmetric dimethylarginine throughout normal pregnancy and in pregnancies complicated by preeclampsia or had a small for gestational age baby","volume":"25","author":"Rizos","year":"2012","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(03)13177-7","article-title":"Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia","volume":"361","author":"Savvidou","year":"2003","journal-title":"Lancet"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/01443615.2012.693984","article-title":"Homocysteine, folate and pregnancy outcomes","volume":"32","author":"Kim","year":"2012","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0002-9378(95)91324-6","article-title":"Underlying disorders associated with severe early onset preeclampsia","volume":"173","author":"Dekker","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1447-0756.2010.01317.x","article-title":"Homocysteine, folic acid and vitamin B12 levels in maternal and umbilical cord plasma and homocysteine levels in placenta in pregnant women with preeclampsia","volume":"37","author":"Acilmis","year":"2011","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12291-011-0109-3","article-title":"Study of serum homocysteine, folic Acid and vitamin B(12) in patients with preeclampsia","volume":"26","author":"Mujawar","year":"2011","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/10641950802601179","article-title":"Association of maternal serum CRP, IL-6, TNF-alpha, homocysteine, folic acid and vitamin B12 levels with the severity of preeclampsia and fetal birth weight","volume":"28","author":"Guven","year":"2009","journal-title":"Hypertens. Pregnancy"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00404-006-0223-2","article-title":"Homocysteine, folic acid and B12 serum levels in pregnancy complicated with preeclampsia","volume":"275","author":"Makedos","year":"2007","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/01.HYP.0000126580.81230.da","article-title":"Homocysteine and folic acid are inversely related in black women with preeclampsia","volume":"43","author":"Patrick","year":"2004","journal-title":"Hypertension"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/aje\/153.5.474","article-title":"Plasma folate, vitamin B(12), and homocyst(e)ine concentrations in preeclamptic and normotensive Peruvian women","volume":"153","author":"Sanchez","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"ref_138","first-page":"2719","article-title":"Increased homocysteine levels exist in women with preeclampsia from early pregnancy","volume":"29","author":"Wadhwani","year":"2016","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1373\/clinchem.2007.097469","article-title":"Effect of Homocysteine Concentration in Early Pregnancy on Gestational Hypertensive Disorders and Other Pregnancy Outcomes","volume":"54","author":"Dodds","year":"2008","journal-title":"Clin. Chem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00404-017-4457-y","article-title":"Maternal serum homocysteine and uterine artery Doppler as predictors of preeclampsia and poor placentation","volume":"296","author":"Maged","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1067\/mob.2001.117304","article-title":"Elevated plasma homocysteine in early pregnancy: A risk factor for the development of severe preeclampsia","volume":"185","author":"Cotter","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1067\/S0002-9378(03)00669-0","article-title":"Elevated plasma homocysteine in early pregnancy: A risk factor for the development of nonsevere preeclampsia","volume":"189","author":"Cotter","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0301-2115(00)00497-8","article-title":"Hyperhomocysteinaemia: A risk factor for preeclampsia?","volume":"95","author":"Raijmakers","year":"2001","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_144","first-page":"527","article-title":"Serum homocysteine at 16 weeks and subsequent preeclampsia","volume":"97","author":"Hietala","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1067\/mob.2000.109044","article-title":"Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction","volume":"183","author":"Hogg","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.19082\/3057","article-title":"The evaluation of serum homocysteine, folic acid, and vitamin B12 in patients complicated with preeclampsia","volume":"8","author":"Shahbazian","year":"2016","journal-title":"Electron. Physician"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/01.CIR.0000085067.55901.89","article-title":"Endothelial dysfunction induced by hyperhomocyst(e)inemia: Role of asymmetric dimethylarginine","volume":"108","author":"Stuhlinger","year":"2003","journal-title":"Circulation"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/plac.1999.0417","article-title":"Folic acid and homocysteine metabolic defects and the risk of placental abruption, preeclampsia and spontaneous pregnancy loss: A systematic review","volume":"20","author":"Ray","year":"1999","journal-title":"Placenta"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1538-7836.2005.01364.x","article-title":"Mechanisms of homocysteinee-induced atherothrombosis","volume":"3","author":"Lentz","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00404-009-1234-6","article-title":"Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia","volume":"282","author":"Mao","year":"2010","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0002-9378(98)70033-X","article-title":"Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation","volume":"179","author":"Powers","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1046\/j.1523-1755.1999.0550031028.x","article-title":"Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus","volume":"55","author":"Wollesen","year":"1999","journal-title":"Kidney Int."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1464-5491.2005.01415.x","article-title":"Reduced plasma total homocysteine concentrations in Type 1 diabetes mellitus is determined by increased renal clearance","volume":"22","author":"Veldman","year":"2005","journal-title":"Diabet. Med."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ki.1997.298","article-title":"Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes","volume":"52","author":"Bostom","year":"1997","journal-title":"Kidney Int."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/1381612033391784","article-title":"Nitric oxide and its role duringpregnancy: From ovulation to delivery","volume":"9","author":"Maul","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1469-0705.1999.14020101.x","article-title":"Nitric oxide donors in pregnancy: Fetomaternal hemodynamic effects induced in mild pre-eclampsia and threatened preterm labor","volume":"14","author":"Luzi","year":"1999","journal-title":"Ultrasound Obstetrics Gynecol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/molehr\/5.10.973","article-title":"Nitric oxide donors stimulate prostaglandin F2\u03b1 and inhibit thromboxane B2 production in the human cervix during the first trimester of pregnancy","volume":"5","author":"Ledingham","year":"1999","journal-title":"Mol. Hum. Reprod."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"253e9","DOI":"10.1097\/AOG.0000000000001518","article-title":"Perinatal and hemodynamic evaluation of Sildenafil citrate for preeclampsia treatment: A randomized controlled trial","volume":"128","author":"Trapani","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1074\/jbc.M603606200","article-title":"Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function","volume":"282","author":"Cardounel","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_160","first-page":"202","article-title":"L-arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release","volume":"6","author":"Facchinetti","year":"1999","journal-title":"J. Soc. Gynecol. Investig."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"d2901","DOI":"10.1136\/bmj.d2901","article-title":"Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: Randomised controlled trial","volume":"342","author":"Espino","year":"2011","journal-title":"BMJ"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jfma.2017.08.005","article-title":"Vitamins supplementation affects the onset of preeclampsia","volume":"117","author":"Fu","year":"2018","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3109\/14767051003677962","article-title":"L-arginine supplementation in women with chronic hypertension: Impact on blood pressure and maternal and neonatal complications","volume":"23","author":"Neri","year":"2010","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"ref_164","first-page":"CD006490","article-title":"Nitric oxide for preventing pre-eclampsia and its complications","volume":"2","author":"Meher","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/10641955.2015.1137586","article-title":"Efficacy of L-arginine for preventing preeclampsia in high risk pregnancies: A double-blind randomized clinical trial","volume":"35","year":"2016","journal-title":"Hypertens. Pregnancy"},{"key":"ref_166","first-page":"2617e20","article-title":"Prophylactic treatment for preeclampsia in high risk teenage primigravida with nitricoxide donors: A pilot study","volume":"29","author":"Abdelrazik","year":"2016","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1475-2891-11-106","article-title":"Effect of beetroot juice on lowering blood pressure in freeliving, disease-free adults: A randomized, placebo-controlled trial","volume":"11","author":"Coles","year":"2012","journal-title":"Nutr. J."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.niox.2018.08.004","article-title":"Effects of dietary nitrate supplementation, from beetroot juice, on blood pressure in hypertensive pregnant women: A randomised, double-blind, placebo-controlled feasibility trial","volume":"80","author":"Ormesher","year":"2018","journal-title":"Nitric Oxide"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1043-2760(98)00127-1","article-title":"Sildenafil Citrate, a Selective Phosphodiesterase Type 5 Inhibitor","volume":"10","author":"Moreland","year":"1999","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejogrb.2011.03.005","article-title":"Sildenafil citrate decreases sFlt-1 and sEng in pregnant l-NAME treated Sprague-Dawley rats","volume":"157","author":"Ramesar","year":"2011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/j.1471-0528.2012.03430.x","article-title":"Sildenafil citrate improves perinatal outcome in fetuses from pre-eclamptic rats","volume":"119","author":"Herraiz","year":"2012","journal-title":"BJOG"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0002-9378(98)70264-9","article-title":"Effects of transdermal nitroglycerin on impedance to flow in the uterine, umbilical, and fetal middle cerebral arteries in pregnancies complicated by preeclampsia and intrauterine growth retardation","volume":"179","author":"Cacciatore","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/uog.8983","article-title":"Transdermal nitroglycerin in patients with severe pre-eclampsia with placental insufficiency: Effect on uterine, umbilical and fetal middle cerebral artery resistance indices","volume":"38","author":"Trapani","year":"2011","journal-title":"Ultrasound Obstet. Gynecol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/11\/2757\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:56:17Z","timestamp":1760187377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/11\/2757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":173,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["ijms20112757"],"URL":"https:\/\/doi.org\/10.3390\/ijms20112757","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,5]]}}}